Document is current
Any future updates will be listed below
-
Authors
Chang, Ming
Chen, Yizhe https://orcid.org/0000-0003-1782-6709
Ogasawara, Ken https://orcid.org/0000-0002-4264-8927
Schmidt, Brian James
Gaohua, Lu https://orcid.org/0000-0003-1701-492X
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Received: 20 March 2024
Accepted: 3 July 2024
First Online: 7 August 2024
Declarations
:
: All trials described were conducted in compliance with the International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice and applicable regulatory requirements. Trial protocols were submitted to an independent review board for review and written approval.
: All patients provided written informed consent to participate in the trials described.
: All authors read and approved publication.
: All authors (MC, YC, KO, BJS, and LG) are employees and stockholders of Bristol Myers Squibb.
